We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for Olutasidenib (Dr Reddys Laboratories Australia Pty Ltd)
Active ingredients
Olutasidenib
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
capsule
Indication
Treatment of patients with IDH1 mutated acute myeloid leukaemia
Therapeutic area
Haematology